# Planning & Evaluation

> **NIH NIH P30** · OREGON HEALTH & SCIENCE UNIVERSITY · 2021 · $247,095

## Abstract

Planning and Evaluation
ABSTRACT
Under the leadership of the Director, Brian Druker, rigorous planning and evaluation efforts continue to be a
critical activity, focused on the ongoing growth and development of the OHSU Knight Cancer Institute (Knight).
Druker shares the responsibility for establishing the vision and strategic plans with the Knight Senior Leadership
composed of Tomasz Beer, M.D. (Deputy Director and Interim Associate Director Clinical Research), Lisa
Coussens, Ph.D. (Associate Director Basic Research), Sara Courtneidge, Ph.D. (Associate Director
Translational Research), Joe Gray, Ph.D. (Associate Director Biophysical Oncology), Ray Bergan, M.D.
(Associate Director Medical Oncology), Kristin Bialobok, M.S.N (Associate Director Administration), and Mary
Stenzel-Poore, Ph.D. (School of Medicine Associate Dean, Research). This group, together with external
advisors, undertook extensive strategic planning and evaluation efforts with the goal of enhancing the
productivity of our center.
Three committees are responsible for the internal governance of the Knight: the Associate Directors Advisory
Group, the Program Leaders and Shared Resource Directors Committee, and the Clinical Executive Group.
These committees are structured to ensure successful operation of the Knight, support new initiatives and to
promote interactions within and between programmatic elements of the Knight.
The External Advisory Board (EAB) is a distinguished group of cancer specialists and is chaired by Dr. Joseph
Simone. The EAB reviews the Knight's scientific progress, vision, and future plans. Further ad hoc discussions
may occur between the Director and EAB members throughout the year. The EAB reviews the organizational
structure, programs, and shared resources providing advice regarding whether each is adding value to the
institute's mission. They evaluate scientific excellence, focus, and interactivity of each program. The EAB
provides formal reports to the Director, which are shared with the OHSU President and Dean of the SOM. The
recommendations of this group have been essential in developing our current leadership and program structure,
and shared resources. The EAB has consistently helped us develop a programmatic structure that optimally
aligns with the strengths of our institute, optimizes the capacity of programs to create trans-disciplinary studies,
and supports inter-programmatic interactions.
To engage the Knight membership in strategic planning, and to stimulate intra- and inter-programmatic member
interactions, routine programmatic meetings, as well as a number of Knight-wide and programmatic retreats
were held. Development Funds, in the form of pilot project awards, were provided to stimulate collaborative
publications and multi-investigator grants. This investment and planning has successfully resulted in an overall
member collaborative publication rate of 39%, as well as a significant increase in multi-investigator grants.

## Key facts

- **NIH application ID:** 10205350
- **Project number:** 5P30CA069533-23
- **Recipient organization:** OREGON HEALTH & SCIENCE UNIVERSITY
- **Principal Investigator:** Kristin Michelle Bialobok
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $247,095
- **Award type:** 5
- **Project period:** 1997-08-01 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10205350

## Citation

> US National Institutes of Health, RePORTER application 10205350, Planning & Evaluation (5P30CA069533-23). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10205350. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*